Call Boomerang Books 1300 36 33 32

Description - Molecular Medical Parasitology by Richard W. Komuniecki

A valuable, new source, Molecular Medical Parasitology is the only text of its kind -- one that applies broad concepts and current scientific advances from both molecular biology and biochemistry to the study of parasitic organisms. An internationally renowned team of scientists and physicians places parasites in their broad biological contexts while still emphasizing the specifics that differentiate these organisms. Not only will researchers and faculty in parasitology find this an indispensable guide, physicians will benefit from the thorough coverage molecular biology and biochemistry's current influences on treatment and management of parasitic diseases.

Buy Molecular Medical Parasitology by Richard W. Komuniecki from Australia's Online Independent Bookstore, Boomerang Books.

Book Details

ISBN: 9780124733466
ISBN-10: 0124733468
Format: Hardback
(241mm x 165mm x mm)
Pages: 488
Imprint: Academic Press Inc
Publisher: Elsevier Science Publishing Co Inc
Publish Date: 9-Dec-2002
Country of Publication: United States

Book Reviews - Molecular Medical Parasitology by Richard W. Komuniecki

» Have you read this book? We'd like to know what you think about it - write a review about Molecular Medical Parasitology book by Richard W. Komuniecki and you'll earn 50c in Boomerang Bucks loyalty dollars (you must be a Boomerang Books Account Holder - it's free to sign up and there are great benefits!)

Write Review


Author Biography - Richard W. Komuniecki

Dr. J. J. Marr has held positions in academic medicine and biochemistry; as Director of Divisions of Infectious Diseases; Vice Chairman, Department of Medicine; and Professor of Medicine, Biochemistry and Microbiology at Washington University, St. Louis University and the University of Colorado. Subsequently, he was Senior Vice Presidnt for Drug Discovery at Searle Pharmaceuticals, acted as a consultant to the National Institutes of Health and the World Health Organization, and now holds the position of Vice President for Research and Development/Chief Scientific Officer, Ribozyme Pharmaceuticals, Inc.